Alex Tong

2.2k citations
32 papers · 1.5k indexed · h-index 14
Topics
Immunotherapy and Immune Responses (7 papers)CAR-T cell therapy research (5 papers)Cancer Research and Treatments (4 papers)
Partner nations
United StatesChinaJapan

In The Last Decade

Alex Tong

31 papers receiving 1.5k citations

Peers

Alex Tong
Comparison fields: 5 of 107
  • Molecular Biology 971
  • Immunology 518
  • Oncology 452
  • Genetics 181
  • Plant Science 96
Replace Javad Nazarian with:
Javad Nazarian United States
Benoit Coulombe Canada
Elmar Wolf Germany
Sigrid S. Skånland Norway
Ken C. Dong United States
Jimmy D. Dikeakos Canada
Radoslav I. Enchev United Kingdom
Wolfgang Paster Austria
Vasily M. Studitsky United States
A V Rutherford United States
Alex Tong relative to Javad Nazarian United States Javad Nazarian's profile →
Citations per field
00.5×4.6×
Javad Nazarian · 1×
Citations per year

Countries citing papers authored by Alex Tong

Since Specialization
Citations

This map shows the geographic impact of Alex Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Tong more than expected).

Fields of papers citing papers by Alex Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Tong. The network helps show where Alex Tong may publish in the future.

Co-authorship network of co-authors of Alex Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Tong. A scholar is included among the top collaborators of Alex Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Tong. Alex Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 7
4 22
5 18
6 6
7 10
8 75
9 136
10 1
11 121
12
Biomarkers Analysis for Heterogeneous Immune Responses of Quiescent CD8+cells -A Clue for Personalized Immunotherapy.
1
13 6
14 50
15 41
16 166
17 8
18 35
19 7
20 1

About Alex Tong

Alex Tong is a scholar working on Structural Biology, Biotechnology and Immunology, having authored 32 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (5 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Structural Biology (35 citations), Immunology (518 citations) and Oncology (452 citations). Alex Tong has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Hao Wu, John Nemunaitis, Tian‐Min Fu, Neil Senzer, Qian Yin, Shuobing Chen, Alvin Lu, Youdong Mao, Phillip B. Maples and Casey Cunningham. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026